Search research articles
Contact Us
Filters
Showing results (431-440 of 509) with videos related to
Page
of 51
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
J Eikenboom, V Van Marion, H Putter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
W I Bensinger, S D Rowley, T Demirer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
U Budde, R Schneppenheim, J Eikenboom, et al.
Bone Marrow Transplantation
|
September 28, 2011
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
O Ringdén, S Shrestha, G T da Silva, et al.
JAMA
|
February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studies
S A Smith-Warner, D Spiegelman, S S Yaun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 31, 2025
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma
M Ebadi, X Fan, G Schoch, et al.
Bone Marrow Transplantation
|
June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease
K S Schiffman, W I Bensinger, F R Appelbaum, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 8, 2006
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J E Sadler, U Budde, J C J Eikenboom, et al.
Leukemia
|
December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time
S K Kumar, A Dispenzieri, R Fraser, et al.
Page
of 51
Search research articles
Search
Showing results (431-440 of 509) with videos related to
Sort By:
Page
of 51
Journal of Thrombosis and Haemostasis : JTH
|
April 26, 2006
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
J Eikenboom, V Van Marion, H Putter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
W I Bensinger, S D Rowley, T Demirer, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
U Budde, R Schneppenheim, J Eikenboom, et al.
Bone Marrow Transplantation
|
September 28, 2011
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
O Ringdén, S Shrestha, G T da Silva, et al.
JAMA
|
February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studies
S A Smith-Warner, D Spiegelman, S S Yaun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 31, 2025
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Haematopoietic Stem Cell Transplantation for Relapsed/Refractory Large B-cell Lymphoma
M Ebadi, X Fan, G Schoch, et al.
Bone Marrow Transplantation
|
June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease
K S Schiffman, W I Bensinger, F R Appelbaum, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 8, 2006
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J E Sadler, U Budde, J C J Eikenboom, et al.
Leukemia
|
December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time
S K Kumar, A Dispenzieri, R Fraser, et al.
Page
of 51